𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MCM7 amplification and overexpression are associated with prostate cancer progression

✍ Scribed by Ren, B; Yu, G; Tseng, G C; Cieply, K; Gavel, T; Nelson, J; Michalopoulos, G; Yu, Y P; Luo, J-H


Book ID
110070167
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
269 KB
Volume
25
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Allelic losses on 18q21 are associated w
✍ Takeshi Ueda; Akira Komiya; Mitsuru Emi; Hiroyoshi Suzuki; Taizo Shiraishi; Ryui πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 2 views

We analyzed normal/tumor DNA pairs obtained from 46 patients with prostate cancers (stage B, 16 cases; C, 10 cases; D1, 4 cases; and endocrine therapy-resistant cancer-death, 16 cases) for loss of heterozygosity using 32 microsatellite markers on chromosome 18. Seventeen of the 46 cases (37%) showed

Expression of CD147 is associated with p
✍ Wei-de Zhong; Yu-xiang Liang; Sharron X. Lin; Ling Li; Hui-chan He; Xue-cheng Bi πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 519 KB

## Abstract Novel molecular markers that are associated with prostate cancer (PCa) progression will provide valuable information in the diagnosis and treatment of the disease. Extracellular matrix metalloproteinase inducer (CD147) has been demonstrated to be involved in tumor invasion, metastasis,